UVA Licensing & Ventures, the commercialisation arm of University of Virginia (UVA), disclosed its first three investments yesterday made from its $10m seed fund.
University of Virginia launched the UVA LVG Seed Fund for UVA-linked companies in 2016 with $5m each from its healthcare research facility UVA Health System and other unspecified sources.
The businesses, which each received undisclosed sums, were named as diabetes management technology developer TypeZero, dry eye disease therapy producer TearSolutions and cybersecurity platform developer Mission Secure.
…